No. 001 (2023): Les Maladies Rénales
This issue features an international clinical practice guide in Chinese medicine focusing on the treatment of diabetes, and a specification for professional training in the dispensing of Chinese pharmacopoeia.
Among the clinical studies, one examines the efficacy of Huangkui capsules in the treatment of albuminuria associated with type 2 diabetic nephropathy. Another retrospective study explores the use of acupuncture to treat chemotherapy-induced leukopenia in 126 patients.
This issue also looks at data mining, which includes a reflection on the development of Chinese medicinal plants in France, based on a comparative analysis of medical prescriptions between China and France. Another analysis examines trends in the use of clinical drugs for diabetes-related kidney disease, using a combination of hidden structures and association rules.
In terms of traditional reviews, this issue presents advances in research into the mechanism of action and clinical efficacy of Baimai Ruangao ointment for pain relief. In terms of theoretical discussions, it looks at the exploration of treatment rules for weakness syndrome based on the theory of simultaneous treatment of different diseases.
Publisher: Centre France Chine de la Médecine Chinoise
Editor-in-chief: Prof. ZHAI Huaqiang, Beijing University of Chinese Medicine
Translation by : Center France Chine de la Médecine Chinoise
Academic reviewers: Dr NHAN Tâm, Dr TILLET Yves, Dr LALLEMAND Frédéric, Dr HUBERT François
Copyright: © 2023 by the authors. Submitted for open access publication under the terms and conditions of the Creative Commons Attribution (CC BY) License (https://creativecommons.org/licenses/by/4.0/).
Published:
2023-12-24
